✦ LIBER ✦

Intravenous γ-globulin treatment in a patient with subacute sclerosing panencephalitis

✍ Scribed by Y.K. Yavuz Gürer; Şenay Kükner; Bige Sarica

Book ID: 116153842
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 296 KB
Volume: 14
Category: Article
ISSN: 0887-8994
DOI: 10.1016/0887-8994(95)00257-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes of γ globulins in serum and cere

Changes of γ globulins in serum and cerebrospinal fluid of patients with subacute sclerosing panencephalitis

✍ A. Peter; A. Lowenthal; I. Juvancz 📂 Article 📅 1974 🏛 Springer 🌐 English ⚖ 405 KB

Cerebrospinal fluid measles antibody tit

Cerebrospinal fluid measles antibody titer and γ globulins in subacute sclerosing panencephalitis

✍ G. Ebinger; G. Matthyssens 📂 Article 📅 1971 🏛 Springer 🌐 English ⚖ 271 KB

Atypical electroencephalographic pattern

Atypical electroencephalographic pattern in a patient with subacute sclerosing panencephalitis

✍ Gregory B. Sharp; S.Mark Laney; Barbara F. Westmoreland; Robert V. Groover 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Isoprinosine treatment in 18 patients wi

Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: A controlled study

✍ Fuad Sami Haddad; Dr Winthrop S. Risk 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB

Treatment of subacute sclerosing panence

Treatment of subacute sclerosing panencephalitis with alpha interferon

✍ Generoso G. Gascon; Soad Yamani; A. Cafege; L. Flock; S. Al-Sedairy; R. S. Parha 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Transfer factor therapy in patients with

Transfer factor therapy in patients with subacute sclerosing panencephalitis

✍ Y. M. Käckell; P. J. Grob; W. H. Kreth; R. Kibler; V. ter Meulen 📂 Article 📅 1975 🏛 Springer 🌐 English ⚖ 674 KB

Thirteen patients with subacute sclerosing panencephalitis (S.S.P.E.) at different stages of the disease were admitted for transfer factor treatment. The transfer factor was prepared from non-selected blood bank donors. The activity of the transfer factor was tested in patients with diseases other t